Indonesia reported an estimated 1.09 million TB cases in 2023. TB-related deaths decreased by 8%, bringing the total to 131,000. Around 285,164 individuals were undiagnosed or unreported, and 25,000 people were estimated to have both TB and HIV. There were 30,000 cases of drug-resistant TB.
In 2018, we joined Indonesia’s national effort to combat TB following an MoU signed between the Ministry of Health of the Republic of Indonesia and the MoH of the Kingdom of the Netherlands.
In 2020, we signed a Letter of Intent with the Indonesian Ministry of Health and registered CAD4TB for use within the country. That same year, we collaborated with Fullerton Health, e-Tirta medical centres, and the Ministry of Health to launch a pilot in prisons and a factory in Jakarta. The project screened around 1,000 people and laid the groundwork for future national deployments.
Our work expanded in 2021 through three Memorandums of Understanding with the Faculty of Medicine at Universitas Indonesia to explore AI, including CAD4TB, CAD4COVID, and RetCAD. We also established Delft Imaging Indonesia, a local office supporting installations, training, and service delivery.
In early 2022, more than 80,000 prisoners were screened through our collaboration with Fullerton Health, e-Tirta medical centres and the Ministry of Health. By the end of that year, CAD4TB had been installed in 16 mobile clinics, covering 25 public health centers, and supporting the screening of an additional 110,000 individuals. That same year, we partnered with International SOS to screen 10,000 mine workers using a mobile van. Another 15,000 employees were screened in early 2023.
In 2023, our partnership with e-Tirta and the Ministry of Health expanded to include the screening of 206,000 prisoners across 374 prisons in 33 provinces. In parallel, a community-based screening initiative covered 15 regions and reached an additional 200,000 people. In 2024, we provided an additional CAD4TB to support our ongoing collaboration with International SOS.
Making a Difference
Research paper
As a long-time partner to Indonesia’s TB screening efforts, researchers studied the use of CAD4TB among Indonesians living with Diabetes Mellitus (PLWD). This was particularly important as Diabetes Mellitus is a significant risk factor for TB. The study, already published in 2018, showed the potential use of CAD4TB as a triage tool for TB screening in PLWD, significantly reducing the need for microbiological examination.
In 2025, a retrospective study of 1,100+ chest X-rays in an Indonesian hospital showed CAD4TB v7 achieved 81% sensitivity and 64% specificity, comparable to radiologists. Its accuracy remained strong among patients without pleural effusion or HIV, and those without prior TB. These results highlight CAD4TB’s value as a reliable triage tool, especially in complex cases and settings lacking immediate radiology expertise.
Webinar insights
For more information on how CAD4TB is used throughout Indonesia, please view the story of ‘Utilization of CAD4TB for Mass and Remote TB-Screening in Indonesia, ‘ presented by Dr Lituhayu B. Putri of Fullerton Health in Indonesia. The story was presented during the 2021 Q3 Delft webinar.
In 2024 Delft Imaging webinar “Innovation in Action: Accelerating TB Screening in Low-Resource Settings with Digital X-rays & CAD,” Dr. Richard Jones, Regional Medical Director at International SOS, shared insights on tackling TB in Indonesia’s high-risk mining environments. The industry adopted innovative strategies, including education, regular health screenings, and AI-powered tools like CAD4TB and CAD4Silicosis, to improve early detection. “The CAD4TB has shown us… we had 22 asymptomatic cases that likely would have gone undetected,” said Dr. Jones. These interventions have significantly reduced TB burden in a workforce of 30,000 employees, setting the stage for broader implementation across the mining sector.
The above figure shows H.E. Budi Gunadi Sadikin, Minister of Health of Indonesia, discussing the utilisation of CAD4TB during the kick-off of the Active Case Finding project to screen 200,000 people with CAD4TB as part of the High Level Tuberculosis Meeting on in Surabaya on November 8th, 2022.
Case studies
Immerse yourself with the case study ‘CAD4TB for Mass & Remote TB Screening’ in Indonesia in 2021. Discover how CAD4TB aligns with radiologist expertise, providing high sensitivity in detecting TB, particularly in high-risk populations.
As part of Indonesia’s national TB program, a large-scale screening initiative was conducted to address TB detection gaps in correctional facilities. Between July and November 2023, 206,345 inmates across 376 prisons were screened using symptom checks, digital X-ray with CAD4TB, and Xpert testing. This approach revealed TB prevalence rates exceeding WHO regional estimates. Read the full 2024 case study “TB prevalence in correctional centers with CAD4TB.”
Press coverage
We have supported several events in Indonesia. Amongst those, we supported the World TB Event at Universitas Indonesia and collaborate actively with Kadin (the Chamber of Commerce) to utilize CAD4TB in workplaces and schools.
In 2022, a news article highlighted our collaboration with Indonesia’s Ministry of Health, emphasizing our joint efforts in combating TB through mass screening initiatives. Leveraging our AI-driven X-ray technology, the initiative aims to enhance the detection and treatment of TB across Indonesia.
In the following year, the University of North Sumatra, the Bakrie Center Foundation, and the Indonesian Chamber of Commerce and Industry introduced the use of X-rays integrated with CAD4TB software for further examinations of students for TB. Read more about it here.
In 2024, the impact of our solutions in the field was reported on how the Indonesian Ministry of Health is utilizing Delft Light, with CAD4TB, to increase early detection of TB in Active Case Finding.
